These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 86987)

  • 1. [Experimental allergic encephalomyelitis--clinical aspects and treatment].
    Błaszczyk B
    Postepy Hig Med Dosw; 1979; 33(1):77-88. PubMed ID: 86987
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen.
    Fujinami RS; Paterson PY
    J Immunol; 1977 Nov; 119(5):1634-8. PubMed ID: 72104
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L; Weigle WO
    J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute allergic encephalomyelitis (EAE) in the rat with special reference to immunologic and demyelinization effects.
    Piliero SJ; Cremonese P
    J Reticuloendothel Soc; 1973 Jul; 14(1):100-18. PubMed ID: 4126715
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
    Ben-Nun A; Cohen IR
    J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of various immunosuppressive drugs on experimental allergic encephalomyelitis in chickens.
    Blaszczyk B; Karakoz I; Gieldanowski J
    Folia Biol (Praha); 1977; 23(6):398-9. PubMed ID: 608476
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
    Panitch H; Ciccone C
    Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of experimental allergic encephalomyelitis by bacterial lipopolysaccharides: inhibition of cell-mediated immunity.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):13-6. PubMed ID: 6165758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of immunoadsorbent treatment in experimental allergic encephalomyelitis].
    Hurina NM; Bardakhivs'ka KI; Kuchmerovs'ka TM
    Fiziol Zh (1994); 2008; 54(6):79-86. PubMed ID: 19227244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat.
    Goihman-Yahr M; Requena MA; Vallecalle-Suegart E; Convit J
    Int J Lepr Other Mycobact Dis; 1974; 42(3):266-75. PubMed ID: 4218599
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic remitting-relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein.
    Shaw CM; Alvord EC; Hruby S
    Ann Neurol; 1988 Dec; 24(6):738-48. PubMed ID: 2462850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys.
    Alvord EC; Shaw CM; Hruby S
    Ann Neurol; 1979 Dec; 6(6):469-73. PubMed ID: 93874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of transfer of allergic encephalomyelitis].
    Orlov AB
    Vestn Akad Med Nauk SSSR; 1967; 22(2):83-5. PubMed ID: 5620909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.